Are Dynamic Arterial Spin-Labeling MRA and Time-Resolved Contrast-Enhanced MRA Suited for Confirmation of Obliteration following Gamma Knife Radiosurgery of Brain Arteriovenous Malformations?


Journal

AJNR. American journal of neuroradiology
ISSN: 1936-959X
Titre abrégé: AJNR Am J Neuroradiol
Pays: United States
ID NLM: 8003708

Informations de publication

Date de publication:
04 2021
Historique:
received: 10 04 2020
accepted: 21 10 2021
pubmed: 6 2 2021
medline: 13 10 2021
entrez: 5 2 2021
Statut: ppublish

Résumé

Intra-arterial DSA has been traditionally used for confirmation of cure following gamma knife radiosurgery for AVMs. Our aim was to evaluate whether 4D arterial spin-labeling MRA and contrast-enhanced time-resolved MRA in combination can be an alternative to DSA for confirmation of AVM obliteration following gamma knife radiosurgery. In this prospective study, 30 patients undergoing DSA for confirmation of obliteration following gamma knife radiosurgery for AVMs (criterion standard) also underwent MRA, including arterial spin-labeling MRA and contrast-enhanced time-resolved MRA. One dataset was technically unsatisfactory, and the case was excluded. The DSA and MRA datasets of 29 patients were independently and blindly evaluated by 2 observers regarding the presence/absence of residual AVMs. The mean time between gamma knife radiosurgery and follow-up DSA/MRA was 53 months (95% CI, 42-64 months; range, 22-168 months). MRA total scanning time was 9 minutes and 17 seconds. Residual AVMs were detected on DSA in 9 subjects (obliteration rate = 69%). All residual AVMs were detected on at least 1 MRA sequence. Arterial spin-labeling MRA and contrast-enhanced time-resolved MRA showed excellent specificity and positive predictive values individually (100%). However, their sensitivity and negative predictive values were suboptimal due to 1 false-negative with arterial spin-labeling MRA and 2 with contrast-enhanced time-resolved MRA (sensitivity = 88% and 77%, negative predictive values = 95% and 90%, respectively). Both sensitivity and negative predictive values increased to 100% if a composite assessment of both MRA sequences was performed. Diagnostic accuracy (receiver operating characteristic) and agreement (κ) are maximized using arterial spin-labeling MRA and contrast-enhanced time-resolved MRA in combination (area under receiver operating characteristic curve = 1, Combining arterial spin-labeling MRA with contrast-enhanced time-resolved MRA holds promise as an alternative to DSA for confirmation of obliteration following gamma knife radiosurgery for brain AVMs, having provided 100% sensitivity and specificity in the study. Their combined use also enables reliable characterization of residual lesions.

Sections du résumé

BACKGROUND AND PURPOSE
Intra-arterial DSA has been traditionally used for confirmation of cure following gamma knife radiosurgery for AVMs. Our aim was to evaluate whether 4D arterial spin-labeling MRA and contrast-enhanced time-resolved MRA in combination can be an alternative to DSA for confirmation of AVM obliteration following gamma knife radiosurgery.
MATERIALS AND METHODS
In this prospective study, 30 patients undergoing DSA for confirmation of obliteration following gamma knife radiosurgery for AVMs (criterion standard) also underwent MRA, including arterial spin-labeling MRA and contrast-enhanced time-resolved MRA. One dataset was technically unsatisfactory, and the case was excluded. The DSA and MRA datasets of 29 patients were independently and blindly evaluated by 2 observers regarding the presence/absence of residual AVMs.
RESULTS
The mean time between gamma knife radiosurgery and follow-up DSA/MRA was 53 months (95% CI, 42-64 months; range, 22-168 months). MRA total scanning time was 9 minutes and 17 seconds. Residual AVMs were detected on DSA in 9 subjects (obliteration rate = 69%). All residual AVMs were detected on at least 1 MRA sequence. Arterial spin-labeling MRA and contrast-enhanced time-resolved MRA showed excellent specificity and positive predictive values individually (100%). However, their sensitivity and negative predictive values were suboptimal due to 1 false-negative with arterial spin-labeling MRA and 2 with contrast-enhanced time-resolved MRA (sensitivity = 88% and 77%, negative predictive values = 95% and 90%, respectively). Both sensitivity and negative predictive values increased to 100% if a composite assessment of both MRA sequences was performed. Diagnostic accuracy (receiver operating characteristic) and agreement (κ) are maximized using arterial spin-labeling MRA and contrast-enhanced time-resolved MRA in combination (area under receiver operating characteristic curve = 1,
CONCLUSIONS
Combining arterial spin-labeling MRA with contrast-enhanced time-resolved MRA holds promise as an alternative to DSA for confirmation of obliteration following gamma knife radiosurgery for brain AVMs, having provided 100% sensitivity and specificity in the study. Their combined use also enables reliable characterization of residual lesions.

Identifiants

pubmed: 33541896
pii: ajnr.A6990
doi: 10.3174/ajnr.A6990
pmc: PMC8041012
doi:

Substances chimiques

Spin Labels 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

671-678

Informations de copyright

© 2021 by American Journal of Neuroradiology.

Auteurs

A Rojas-Villabona (A)

From The Gamma Knife Centre at Queen Square (A.R.-V.) a.villabona.11@ucl.ac.uk.
Department of Neurosurgery (A.R.-V.), Royal Victoria Infirmary, Newcastle upon Tyne, UK.

F B Pizzini (FB)

Department of Radiology (F.B.P., R.I.F.), Department of Diagnostic and Public Health, Verona University, Verona, Italy.

T Solbach (T)

The Lysholm Department of Neuroradiology (T.S., H.R.J.).

M Sokolska (M)

Department of Medical Physics and Bioengineering (M.S.).
Neuroradiological Academic Unit (M.S., X.G., H.R.J.).

G Ricciardi (G)

Neuroradiology Unit (G.R., C.L.), Department of Diagnostic and Pathology, University Hospital of Verona, Verona, Italy.

C Lemonis (C)

Neuroradiology Unit (G.R., C.L.), Department of Diagnostic and Pathology, University Hospital of Verona, Verona, Italy.

E DeVita (E)

School of Biomedical Engineering and Imaging Sciences (E.D.V.), King's College London, London, UK.

Y Suzuki (Y)

Wellcome Centre for Integrative Neuroimaging (Y.S.), FMRIB, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.

M J P van Osch (MJP)

C.J. Gorter Center for High Field MRI (M.J.P.v.O.), Department of Radiology, Leiden University Medical Center, Leiden, Netherlands.

R I Foroni (RI)

Department of Radiology (F.B.P., R.I.F.), Department of Diagnostic and Public Health, Verona University, Verona, Italy.

M Longhi (M)

Department of Neuroscience (M.L., A.N.).

D Atkinson (D)

Department of Brain Repair and Rehabilitation, Institute of Neurology and Centre for Medical Imaging (D.A.), University College London, London, UK.

N Kitchen (N)

Department of Neurosurgery (N.K.), National Hospital for Neurology and Neurosurgery, London, UK.

A Nicolato (A)

Department of Neuroscience (M.L., A.N.).

X Golay (X)

Neuroradiological Academic Unit (M.S., X.G., H.R.J.).

H R Jäger (HR)

The Lysholm Department of Neuroradiology (T.S., H.R.J.).
Neuroradiological Academic Unit (M.S., X.G., H.R.J.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH